Cobra Biologics Overview
Company Headquarters: Keele, Northern Staffordshire, England
Founded: 1992
Workforce: 201-500+
Company Working:
Cobra Biologics was formerly known as RecipharmCobra Biologics Limited and operates as a subsidiary of Recip AB. it is a major player in the contract development and manufacturing (CDMO) segment which provides services such as pre-clinical, clinical, and commercial supply. The company operates in more than 18 counties and has manufacturing unit in Södertälje, Sweden. The company offers API services in pre-filled syringes, freeze drying/lyophilization, and injectable vial fill finish. It operates through DNA, viral vectors, technical proteins, microbiota, fill finish and other segments. The company has a strong research and development with more than 320 products in pipeline.
Strategy
Cobra Biologics emphasizes on applying high level technology and its expertise in the field to provide unmatched service to the customers. The company also focuses on expanding category leadership to drive growth worldwide. Moreover, the company focuses on the production of DNA, Virus, protein, microbiota in order to achieve a competitive edge over the other key players in the market. Moreover, the company concentrates on establishing long term partnership with existing customers.



